Diana M Shih Selected Research

Diana M Shih Research Topics

Disease

19	Atherosclerosis 12/2021 - 04/2002
6	Obesity 12/2021 - 04/2007
4	Inflammation (Inflammations) 12/2021 - 09/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 01/2015
3	Hyperhomocysteinemia 01/2012 - 06/2007
2	Fibrosis (Cirrhosis) 12/2021 - 12/2021
2	Heart Failure 02/2021 - 01/2018
2	Dyslipidemias (Dyslipidemia) 10/2020 - 01/2019
2	Atherosclerotic Plaque (Atheroma) 10/2020 - 09/2013
2	Fatty Liver 01/2019 - 04/2013
2	Hyperlipidemias (Hyperlipidemia) 01/2019 - 02/2013
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2019 - 01/2018
2	Coronary Artery Disease (Coronary Atherosclerosis) 02/2016 - 07/2011
2	Hepatocellular Carcinoma (Hepatoma) 01/2015 - 02/2006
2	Inborn Genetic Diseases (Disease, Hereditary) 06/2009 - 06/2007
1	Cardiomegaly (Heart Hypertrophy) 12/2021
1	Kidney Diseases (Kidney Disease) 12/2021
1	Chronic Renal Insufficiency 12/2021
1	Hypertrophy 12/2021
1	Rheumatoid Arthritis 10/2020
1	Arthritis (Polyarthritis) 10/2020
1	Glucose Intolerance 01/2019
1	Thrombosis (Thrombus) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2017
1	Body Weight (Weight, Body) 04/2015
1	Cholelithiasis 04/2015
1	Gallstones (Gallstone) 04/2015
1	Acute Coronary Syndrome 09/2013
1	Seizures (Absence Seizure) 01/2012
1	Alzheimer Disease (Alzheimer's Disease) 01/2012
1	Pseudomonas Infections 11/2011
1	Nutrition Disorders (Nutritional Disorders) 06/2009
1	Vascular Diseases (Vascular Disease) 06/2007

Drug/Important Bio-Agent (IBA)

10	Aryldialkylphosphatase (Paraoxonase)IBA 10/2020 - 07/2002
9	trimethyloxamine (trimethylamine N-oxide)IBA 12/2021 - 01/2013
6	LipidsIBA 10/2020 - 07/2002
6	dimethylaniline monooxygenase (N-oxide forming) (flavin-containing monooxygenase)IBA 01/2019 - 01/2013
4	Proteins (Proteins, Gene)FDA Link 10/2020 - 01/2005
4	CholesterolIBA 04/2015 - 03/2003
3	Choline (Choline Chloride)IBA 12/2021 - 02/2016
3	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 01/2015
3	trimethylamineIBA 12/2021 - 01/2015
3	Antisense OligonucleotidesIBA 01/2019 - 01/2015
3	LDL Receptors (LDL Receptor)IBA 01/2019 - 09/2013
3	EnzymesIBA 01/2017 - 07/2002
3	ApolipoproteinsIBA 04/2015 - 07/2006
3	Methionine (L-Methionine)FDA Link 09/2013 - 06/2007
3	HomocysteineIBA 01/2012 - 06/2007
3	homocysteine thiolactoneIBA 01/2012 - 06/2007
3	Lipoproteins (Lipoprotein)IBA 10/2006 - 07/2002
3	oxidized low density lipoproteinIBA 07/2005 - 04/2002
2	CollagenIBA 12/2021 - 10/2020
2	Insulin (Novolin)FDA Link 01/2019 - 01/2019
2	AntioxidantsIBA 01/2019 - 02/2013
2	Bile Acids and Salts (Bile Acids)IBA 04/2015 - 09/2013
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 09/2013 - 02/2013
2	HDL LipoproteinsIBA 09/2013 - 07/2005
2	Cystathionine beta-Synthase (Serine Sulfhydrase)IBA 06/2009 - 06/2007
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 06/2009 - 06/2007
2	Nitric Oxide Synthase (NO Synthase)IBA 07/2006 - 04/2002
1	CreatinineIBA 12/2021
1	ChemokinesIBA 12/2021
1	Cystatin CIBA 12/2021
1	LigandsIBA 12/2021
1	Adenine FDA LinkGeneric 12/2021
1	Sucrose (Saccharose)IBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	Apolipoproteins E (ApoE)IBA 12/2021
1	Glutathione (Reduced Glutathione)IBA 10/2020
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	Vehicle Emissions (Emissions, Vehicle)IBA 01/2019
1	Oleic Acid (Oleate)IBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Mitogen-Activated Protein KinasesIBA 02/2016
1	CholatesIBA 04/2015
1	Triglycerides (Triacylglycerol)IBA 01/2015
1	OxysterolsIBA 01/2015
1	hyodeoxycholic acidIBA 09/2013
1	Peroxidase (Myeloperoxidase)IBA 09/2013
1	Tyrosine (L-Tyrosine)FDA Link 09/2013
1	Oxidants (Oxidizing Agents)IBA 09/2013
1	Anabolic AgentsIBA 02/2013
1	Parathyroid Hormone (Parathormone)IBA 02/2013
1	Peptides (Polypeptides)IBA 02/2013
1	LactonesIBA 11/2011
1	Phospholipids (Phosphatides)FDA LinkGeneric 11/2011
1	Folic Acid (Vitamin M)FDA LinkGeneric 06/2009
1	Heme Oxygenase-1IBA 06/2007
1	Methionine-tRNA LigaseIBA 06/2007
1	Messenger RNA (mRNA)IBA 02/2006
1	Protein Isoforms (Isoforms)IBA 04/2002
1	Superoxides (Superoxide)IBA 04/2002

Therapy/Procedure

2	Therapeutics 02/2021 - 07/2011
1	Oral Administration 02/2013
1	Intraperitoneal Injections 01/2012